XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.2
Insider Trading Arrangements - Dr. Efthymios Deliargyris
3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

On June 13, 2025, Dr. Efthymios Deliargyris, our Chief Medical Officer, adopted a Rule 10b5-1 trading plan for the sale of the Company’s common stock. The plan, which has a term of one year, provides for the sale of up to 157,500 incentive stock options through market or limit orders.

Name Dr. Efthymios Deliargyris
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date Jun. 13, 2025
Aggregate Available 157,500